CompletedNot Applicable

Nutrition Ameliorates the Muscle Loss of Pre-sarcopenia in Elderly

Taiwan60 participantsStarted 2021-12-24

Plain-language summary

This study evaluates the effects of a 12-week leucine-enriched protein supplementation in adults aged 60 years and more. Participants will undergo assessments of muscle mass and function, as well as metabolic profiles in blood, urine, and feces before and after the intervention.

Who can participate

Age range60 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Willing to provide written informed consent.
✓. Participants who attend health check-ups at Songshan District, Taipei City, or at the Wellness Cultural Village, or who have participated in the pilot study.
✓. Adults aged 60 years or older, male or female.
✓. Able to ambulate independently.
✓. Meets at least one of the following sarcopenia criteria:

Exclusion criteria

✕. Impaired renal function.
✕. Allergy or intolerance to protein supplements.
✕. Currently undergoing cancer treatment.
✕. Autoimmune diseases.
✕. Assessed by a physician as unsuitable to participate.

What they're measuring

Appendicular Skeletal Muscle Index (ASMI)

Timeframe: Baseline and 12 weeks after intervention

Handgrip Strength (HGS)

Timeframe: Baseline and 12 weeks after intervention

Gait speed (m/s)

Timeframe: Baseline and 12 weeks after intervention

Trial details

NCT IDNCT07309120

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-31

View on ClinicalTrials.gov More Low Muscle Mass trials